Candriam Equities L Biotech.I-H EUR Acc/ LU1006082199 /
NAV23/05/2024 | Chg.-35.7001 | Type de rendement | Focus sur l'investissement | Société de fonds |
---|---|---|---|---|
2,032.9000EUR | -1.73% | reinvestment | Equity Worldwide | Candriam ▶ |
NAV23/05/2024 | Chg.-35.7001 | Type de rendement | Focus sur l'investissement | Société de fonds |
---|---|---|---|---|
2,032.9000EUR | -1.73% | reinvestment | Equity Worldwide | Candriam ▶ |